NMR reveals site-specific structural signatures of therapeutic antibodies without isotope labeling

Monoclonal antibodies are widely used to treat diseases ranging from cancer to autoimmune disorders. The safety and efficacy of these biologic drugs depend on maintaining their correct three-dimensional organization, known as their higher-order structure (HOS).

Originally published at Phys.org